Compare HROW & WS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HROW | WS |
|---|---|---|
| Founded | 1998 | 1955 |
| Country | United States | United States |
| Employees | N/A | 5400 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.0B |
| IPO Year | 2008 | 2023 |
| Metric | HROW | WS |
|---|---|---|
| Price | $28.03 | $40.55 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $65.00 | N/A |
| AVG Volume (30 Days) | ★ 555.6K | 439.7K |
| Earning Date | 11-09-2026 | 10-06-2026 |
| Dividend Yield | N/A | ★ 1.61% |
| EPS Growth | ★ 71.43 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $3,443,800,000.00 |
| Revenue This Year | $28.59 | $11.55 |
| Revenue Next Year | $53.17 | $0.38 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 11.33 |
| 52 Week Low | $26.96 | $27.22 |
| 52 Week High | $54.98 | $49.17 |
| Indicator | HROW | WS |
|---|---|---|
| Relative Strength Index (RSI) | 33.95 | 64.61 |
| Support Level | N/A | $32.56 |
| Resistance Level | $35.87 | $44.17 |
| Average True Range (ATR) | 1.33 | 1.87 |
| MACD | -0.04 | 0.40 |
| Stochastic Oscillator | 25.57 | 91.47 |
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.
Worthington Steel Inc is a value-added metals processors with the ability to provide a diversified products and services that span a variety of end markets. It is a value-added processor of carbon flat-rolled steel and a producer of laser welded solutions and electrical steel laminations. It is one of the independent intermediate processors of carbon flat-rolled steel in the U.S. It occupy a niche in the steel industry by focusing on products requiring exact specifications. The company has one operating and reportable segment. It has presence in United States, Canada, Mexico, and Rest of world. The company has majority of sales from United States.